Future research should focus on elucidating colchicine’s effects on inflammatory cells concerning NLRP3 inflammasome; assessing potential benefits and risks in managing ischemic heart disease and developing therapies targeting IL-1β and NLRP3 pathways or inhibiting inflammasome activity. Here, NLRP3 is linked to coronary artery disorder.